Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
-17.37%
↓ 182% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
21.26%
Historical baseline
PeriodValue
Q3 2025-17.37%
Q2 2025-13.10%
Q1 2025-14.44%
Q4 2024-10.19%
Q3 2024-6.59%
Q2 2024-6.89%
Q1 2024418.63%
Q4 2023-18.70%
Q3 2023-76.28%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%